According to Atai Life Sciences's latest financial reports the company has $0.17 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.27 B | -24.61% |
2021-12-31 | $0.36 B | 272.53% |
2020-12-31 | $97.24 M | 223.48% |
2019-12-31 | $30.06 M |